Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses

ConclusionHD on day 2 instead of 3 may prevent hyperammonemia in 5FU/LV therapy.

http://link.springer.com/10.1007/s00280-020-04158-1

Source: Cancer Chemotherapy and Pharmacology - October 29, 2020 Category: Cancer & Oncology Source Type: research

More News: Cancer | Cancer & Oncology | Chemotherapy | Dialysis | Drugs & Pharmacology | Emergency Medicine | Gastric (Stomach) Cancer | Gastroenterology | Hemodialysis | Palliative | Renal Failure